Angel Velarde Lopez

Dr. Angel Velarde Lopez is a physician, researcher, and professor based in Guatemala, with dual expertise in medical physiology and clinical epidemiology. He holds a faculty position at the School of Medicine, University of San Carlos de Guatemala, and serves as the Department Director of Research at Liga Nacional Contra el Cáncer. He earned a Master of Science in Clinical Epidemiology from the University of Pennsylvania through an NIH scholarship, mentored by Dr. Brian L. Strom.

• Medical Degree: University of San Carlos School of Medicine, Guatemala
• MSCE: University of Pennsylvania, NIH Scholarship
• Continuing Education: Harvard School of Medicine (Electrocardiography)

His research focuses on global oncology, particularly cancer epidemiology, radiotherapy access, and health disparities in low- and middle-income countries. He has led and contributed to studies on breast, colon, liver, and brain cancers, with a strong emphasis on improving treatment quality and equity. His work in radiotherapy modernization in Guatemala — transitioning from cobalt-60 to linear accelerators — has been widely published and recognized as a model for LMICs.

Dr. Velarde’s recent publications reveal a consistent focus on cancer care delivery, predictive modeling (e.g., Lynch Syndrome), antimicrobial resistance, and implementation science. His collaborative research spans institutions in the U.S., Guatemala, and Taiwan, reflecting a transnational approach to global health challenges. His work often integrates clinical medicine with public health and health systems research.

Scientific Awards:

• NIH Scholarship for MSCE at University of Pennsylvania

Dr. Velarde has been actively involved in mentoring and global health education initiatives. He has contributed to simulation-based medical training and has worked on projects funded by international collaborations, including partnerships with the University of Pennsylvania’s Center for Global Health. While no formal list of advisees is provided, his leadership roles suggest active involvement in training future physicians and researchers.

He is a key figure in advancing cancer research and treatment in Guatemala, working at the intersection of clinical practice, epidemiology, and health policy. His leadership in radiotherapy quality improvement and cancer epidemiology underscores his role in building sustainable oncology infrastructure in resource-limited settings.